AMG 714 Expanded Access Program
Status
Conditions
Celiac Disease
Treatments
Biological: AMG 714
Details and patient eligibility
About
Expanded access requests for AMG 714 may be considered for adult patients with biopsy proven Refractory Celiac Disease Type II who have failed all available treatment options and do not have EATL. To request access, use Responsible Party contact information provided in this record.
Sex
Ages
18+ years old
Volunteers
No Healthy Volunteers
Inclusion criteria
Exclusion criteria
Trial contacts and locations
0
Loading...
Central trial contact
Amgen Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems